Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 213       
ORIGINAL ARTICLE
Year : 2013  |  Volume : 138  |  Issue : 5  |  Page : 762-765

Approaches to the treatment of disease induced by chikungunya virus


Emerging Viruses & Inflammation Research Group, Institute for Glycomics, Griffith University, Queensland, Australia

Correspondence Address:
Suresh Mahalingam
Emerging Viruses & Inflammation Research Group, Institute for Glycomics Griffith University (Gold Coast Campus), Queensland 4222
Australia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 24434329

Rights and PermissionsRights and Permissions

Chikungunya virus, a re-emerging mosquito-borne alphavirus, causes fever, rash and persistent arthralgia/arthritis in humans. Severe outbreaks have occurred resulting in infections of millions of people in Southeast Asia and Africa. Currently there are no antiviral drugs or vaccines for prevention and treatment of chikungunya infections. Herein we report the current status of research on antiviral drugs and vaccines for chikungunya virus infections.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2050    
    Printed33    
    Emailed0    
    PDF Downloaded882    
    Comments [Add]    

Recommend this journal